2010 JP Morgan Healthcare Conference
News + Events
_of_IMG_0330_medium.JPG "Canaan's Art and Wine Reception")
Canaan Art and Wine Reception
Kristen Hege, Theraclone Sciences; George Painter, Chimerix; Brent Ahrens, Canaan Partners; David Fanning, Theraclone Sciences
Canaan Art and Wine Reception
Canaan's Maha Ibrahim with Chris Cummings, Torrey Pines Investment and Kristin Wynholds, Solipsis Design
_of_IMG_0341_medium.JPG "Canaan Art and Wine Reception")
Canaan Art and Wine Reception
Nathan Stacy, Mayo Foundation with David B. Stewart and Anand Hari, GE Asset Management
Canaan Art and Wine Reception
Brian Campion, Ora, Inc., Brad Stewart, Cylex (center) and Stephen Bloch, Canaan Partners
Canaan Art and Wine Reception
VaxInnate's Alan Shaw and Thomas Hofstaetter with Vimal Mehta, BioXcel (center)
Canaan Wine and Art Reception
Canaan's Seth Rudnick with David Fanning, Theraclone Sciences and Wendy Painter, Chimerix
Canaan's Art and Wine Reception
Canaan's Healthcare Team: Brent Ahrens, Seth Rudnick, Wende Hutton, Peter Farina, Stephen Bloch, Tim Shannon and Santhosh Vadivelu
Canaan's Art and Wine Reception
Kai Zhang and Michael Niesman, MingSight Pharmaceuticals; David Kim, Pinnacle Ventures;
Canaan's Art and Wine Reception
Michael Lachman, Lachman Consulting and Sean Baca, Caisson Capital Partners
Canaan's Art and Wine Reception
Jennifer DePalma and Sam Zucker, O'Melveny & Myers; Wende Hutton, Canaan Partners
Canaan's Art and Wine Reception
Canaan's Stephen Bloch; Eugene Chiu, Predictive BioSciences; Neal Fowler and Kyle Chenet, Liquidia Technologies
Canaan's Art and Wine Reception
Alan Kaganov, US Venture Partners; Oded Ben-Joseph, Deep Vein Medical
Canaan's Art and Wine Reception
Kim Richards and Kara Depolo, Porter Novelli Life Sciences; Alan Shaw, VaxInnate
Canaan's Art and Wine Reception
Robert A. Beardsley and Jerry Colca, Metabolic Solutions Development; Bill Domann, the Domann Organization, Mark Olesnavage, Hopen Therapeutics
Canaan's Art and Wine Reception
Mike Cardone, Eutropics; Anne DeGheest, MedStars; James Shay and Peggy Powers with Shay Glenn, LLP
Canaan's Art and Wine Reception
Relievant-developing a new therapy that offers hope of a future free from chronic back pain
Canaan's Art & Wine Reception
Liquidia Technologies is developing highly precise particle-based vaccines and therapeutics for the prevention and treatment of human disease.
Canaan's Art and Wine Reception
Chimerix, Inc. develops orally-available, highly potent antiviral drugs for life threatening diseases such as smallpox and HIV
_of_IMG_0337_medium.JPG "Canaan's Art and Wine Reception")
Canaan's Art and Wine Reception
CoAxia has developed a unique method of increasing cerebral perfusion for the acute treatment of ischemic stroke and related conditions
Canaan Art and Wine Reception
Advanced BioHealing delivering the promise of regenerative medicine today
Canaan's Art & Wine Reception
_of_IMG_0340_medium.JPG "Canaan's Art & Wine Reception")
ORTHOCON develops and manufactures innovative implants that deliver therapeutics to bone
_of_IMG_0333_medium.JPG "Canaan's Art and Wine Reception")
Canaan's Art and Wine Reception
_of_IMG_0332_medium.JPG "Canaan's Art and Wine Reception")
Marinus Pharmaceuticals and VaxInnate were among the companies featured at this event
Press Contacts
Gina Vakili
Canaan Partners
650 854 8092 - office
650 315 1161 - mobile
.(JavaScript must be enabled to view this email address)
Erin McMahon-Lyman
Magnify Communications
415 307 9962
.(JavaScript must be enabled to view this email address)
Kimberlee Richards
Canale Communications
619 203 5391
.(JavaScript must be enabled to view this email address)
